Trial site
Meldola-Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.)
- 1running trial
- 0closed trials
- 0trials confirmed by the site in the last 60 days
- –languages not stated
No trial has been confirmed here yet.
Running trials
Active, not recruiting
Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
Researchers
No researcher is linked here yet.
Site data: ClinicalTrials.govUpdated 12 Nov 2026